These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7658314)

  • 21. Decreased ferritin levels, despite iron supplementation, during erythropoietin therapy in anaemia of prematurity.
    Bader D; Blondheim O; Jonas R; Admoni O; Abend-Winger M; Reich D; Lanir A; Tamir A; Eldar I; Attias D
    Acta Paediatr; 1996 Apr; 85(4):496-501. PubMed ID: 8740313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant human erythropoietin in the anemia of prematurity: results of a placebo-controlled pilot study.
    Shannon KM; Mentzer WC; Abels RI; Freeman P; Newton N; Thompson D; Sniderman S; Ballard R; Phibbs RH
    J Pediatr; 1991 Jun; 118(6):949-55. PubMed ID: 2040933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant human erythropoietin therapy in low-birthweight preterm infants: a prospective controlled study.
    Arif B; Ferhan K
    Pediatr Int; 2005 Feb; 47(1):67-71. PubMed ID: 15693870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants.
    Pollak A; Hayde M; Hayn M; Herkner K; Lombard KA; Lubec G; Weninger M; Widness JA
    Pediatrics; 2001 Jan; 107(1):78-85. PubMed ID: 11134438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erythropoietin, protein, and iron supplementation and the prevention of anaemia of prematurity.
    Bechensteen AG; Hågå P; Halvorsen S; Whitelaw A; Liestøl K; Lindemann R; Grøgaard J; Hellebostad M; Saugstad OD; Grønn M
    Arch Dis Child; 1993 Jul; 69(1 Spec No):19-23. PubMed ID: 8346946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant human erythropoietin in the treatment of infants with anaemia of prematurity.
    Halpérin DS; Félix M; Wacker P; Lacourt G; Babel JF; Wyss M
    Eur J Pediatr; 1992 Sep; 151(9):661-7. PubMed ID: 1396927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of erythropoietin on the transfusion requirements of preterm infants weighing 750 grams or less: a randomized, double-blind, placebo-controlled study.
    Ohls RK; Harcum J; Schibler KR; Christensen RD
    J Pediatr; 1997 Nov; 131(5):661-5. PubMed ID: 9403642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Usefulness of erythropoietin in the treatment of anemia of prematurity. Influence of birth weight].
    Carbonell Estrany X; Figueras Aloy J; Pérez Fernández JM; Fernández López A; González Luis G; Salvía Roiges MD
    An Esp Pediatr; 1999 Sep; 51(3):281-6. PubMed ID: 10575752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of recombinant human erythropoietin on circulating hematopoietic progenitor cells in anemic premature infants.
    Meister B; Maurer H; Simma B; Kern H; Ulmer H; Hittmair A; Fink FM
    Stem Cells; 1997; 15(5):359-63. PubMed ID: 9323798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birth weight: a multicenter, randomized, controlled trial.
    Ohls RK; Ehrenkranz RA; Wright LL; Lemons JA; Korones SB; Stoll BJ; Stark AR; Shankaran S; Donovan EF; Close NC; Das A
    Pediatrics; 2001 Oct; 108(4):934-42. PubMed ID: 11581447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controlled multicentre study of the influence of subcutaneous recombinant human erythropoietin on anaemia and transfusion dependency in patients with ovarian carcinoma treated with platinum-based chemotherapy.
    ten Bokkel Huinink WW; de Swart CA; van Toorn DW; Morack G; Breed WP; Hillen HF; van der Hoeven JJ; Reed NS; Fairlamb DJ; Chan SY; Godfrey KA; Kristensen GB; van Tinteren H; Ehmer B
    Med Oncol; 1998 Sep; 15(3):174-82. PubMed ID: 9819794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of different dosing regimens for recombinant human erythropoietin in a simulated perisurgical setting: the importance of iron availability in optimizing response.
    Rutherford CJ; Schneider TJ; Dempsey H; Kirn DH; Brugnara C; Goldberg MA
    Am J Med; 1994 Feb; 96(2):139-45. PubMed ID: 8109598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does early erythropoietin therapy decrease transfusions in anemia of prematurity?
    Atasay B; Günlemez A; Akar N; Arsan S
    Indian J Pediatr; 2002 May; 69(5):389-91. PubMed ID: 12061670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of recombinant human erythropoietin in the treatment of anemia of prematurity].
    Rosati E; Latini G; De Mitri B; Quartulli L; Caliandro P
    Pediatr Med Chir; 1995; 17(1):45-8. PubMed ID: 7739926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. rhEPO treatment of postpartum anemia.
    Zimmermann R; Breymann C; Richter C; Huch R; Huch A
    J Perinat Med; 1995; 23(1-2):111-7. PubMed ID: 7658310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacologic doses of recombinant human erythropoietin in the treatment of myelodysplastic syndromes.
    Stein RS; Abels RI; Krantz SB
    Blood; 1991 Oct; 78(7):1658-63. PubMed ID: 1912554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimal timing of repeated rh-erythropoietin administration improves its effectiveness in stimulating erythropoiesis in healthy volunteers.
    Breymann C; Bauer C; Major A; Zimmermann R; Gautschi K; Huch A; Huch R
    Br J Haematol; 1996 Feb; 92(2):295-301. PubMed ID: 8602988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors related to transfusion in very low birthweight infants treated with erythropoietin.
    Maier RF; Obladen M; Messinger D; Wardrop CA
    Arch Dis Child Fetal Neonatal Ed; 1996 May; 74(3):F182-6. PubMed ID: 8777681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of treatment results for anemia of prematurity treated with various doses of human recombinant erythropoietin].
    Lauterbach R; Kachlik P; Pawlik D; Bajorek I
    Pediatr Pol; 1995 Sep; 70(9):739-44. PubMed ID: 8657506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant human erythropoietin in transfusion-dependent anemic patients with multiple myeloma and non-Hodgkin's lymphoma--a randomized multicenter study. The European Study Group of Erythropoietin (Epoetin Beta) Treatment in Multiple Myeloma and Non-Hodgkin's Lymphoma.
    Osterborg A; Boogaerts MA; Cimino R; Essers U; Holowiecki J; Juliusson G; Jäger G; Najman A; Peest D
    Blood; 1996 Apr; 87(7):2675-82. PubMed ID: 8639883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.